Modeling HCV Elimination Recovery Following the COVID-19 Pandemic in the United States: Pathways to Regain Progress
Summary As of 2019, the United States (US) was not on track to achieve targets for elimination, due to increasing incidence and treatment barriers. In 2020, the COVID-19 pandemic disrupted HCV services globally and in the US. As healthcare services normalize, there is an urgent need to reassess progress and evaluate scenarios that restore a […]
English 
Spanish 
French 
Russian 
Arabic